Discover why Argan offers a compelling risk-reward profile and strong upside potential. Click here to read my analysis of AGX stock.

OXY may sell OxyChem to Berkshire Hathaway for $10B, impacting debt and diversification. See the deal’s risks and if now is the time to hold or invest.